Background Thrombin has a pivotal role in the pathogenesis ofacute coronary thrombosis. We compared the clinical efficacyof a potent, direct thrombin inhibitor, recombinant hirudin,with that of heparin (an indirect antithrombin agent) in patientswith unstable angina or acute myocardial infarction.
Methods At 373 hospitals in 13 countries, 12,142 patients withacute coronary syndromes were randomly assigned to 72 hoursof therapy with either intravenous heparin or hirudin. Patientswere stratified according to the presence of ST-segment elevationon the base-line electrocardiogram (4131 patients) or its absence(8011 patients), with the latter characteristic considered toindicate unstable angina or non–Q-wave myocardial infarction.
Results At 24 hours, the risk of death or myocardial infarctionwas significantly lower in the group assigned to hirudin therapythan in the group assigned to heparin (1.3 percent vs. 2.1 percent,P = 0.001). The primary end point of death or nonfatal myocardialinfarction or reinfarction at 30 days was reached in 9.8 percentof the heparin group as compared with 8.9 percent of the hirudingroup (odds ratio for the risk of the end point in the hirudingroup, 0.89; 95 percent confidence interval, 0.79 to 1.00; P= 0.06). The predominant effect of hirudin was on myocardialinfarction or reinfarction and was not influenced by ST-segmentstatus. There were no significant differences in the incidenceof serious or life-threatening bleeding complications, but hirudintherapy was associated with a higher incidence of moderate bleeding(8.8 percent vs. 7.7 percent, P = 0.03).
Conclusions For acute coronary syndromes, recombinant hirudinprovided a small advantage, as compared with heparin, principallyrelated to a reduction in the risk of nonfatal myocardial infarction.The relative therapeutic effect was more pronounced early (at24 hours) but dissipated over time. The small benefit was consistentacross the spectrum of acute coronary syndromes and was notassociated with a greater risk of major bleeding complications.
Source Information
Dr. Topol, as study chairman, is responsible for the content of the article.
Address reprint requests to Dr. Eric J. Topol at the Cleveland Clinic Foundation, Dept. of Cardiology F/25, 9500 Euclid Ave., Cleveland, OH 44195.
Coronary Artery Disease in Men and Women
Rosén M., Spetz C.-L., Hammar N., Greenland P., Goldbourt U., Cao L., Song W., Ornstein D. L., Zacharski L. R., Vaccarino V., Hochman J. S., Thompson T. D.
Extract |
Full Text
N Engl J Med 1999;
341:1931-1935, Dec 16, 1999.
Correspondence
This article has been cited by other articles:
Berger, J. S., Elliott, L., Gallup, D., Roe, M., Granger, C. B., Armstrong, P. W., Simes, R. J., White, H. D., Van de Werf, F., Topol, E. J., Hochman, J. S., Newby, L. K., Harrington, R. A., Califf, R. M., Becker, R. C., Douglas, P. S.
(2009). Sex Differences in Mortality Following Acute Coronary Syndromes. JAMA
302: 874-882
[Abstract][Full Text]
Pogue, J., Walter, S. D, Yusuf, S.
(2009). Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs. Clin Trials
6: 239-251
[Abstract]
Potsis, T. Z., Katsouras, C., Goudevenos, J. A.
(2009). Avoiding and Managing Bleeding Complications in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes. ANGIOLOGY
60: 148-158
[Abstract]
Hollenberg, S. M.
(2009). Acute Coronary Syndromes. ACCP Crit Care Med Brd Rev
20: 129-144
[Full Text]
Shishehbor, M. H., Madhwal, S., Rajagopal, V., Hsu, A., Kelly, P., Gurm, H. S., Kapadia, S. R., Lauer, M. S., Topol, E. J.
(2009). Impact of Blood Transfusion on Short- and Long-Term Mortality in Patients With ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol Intv
2: 46-53
[Abstract][Full Text]
Dey, S, Flather, M D, Devlin, G, Brieger, D, Gurfinkel, E P, Steg, P G, FitzGerald, G, Jackson, E A, Eagle, K A, for the GRACE investigators,
(2009). Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events. Heart
95: 20-26
[Abstract][Full Text]
Lopes, R D, Pieper, K S, Horton, J R, Al-Khatib, S M, Newby, L K, Mehta, R H, Van de Werf, F, Armstrong, P W, Mahaffey, K W, Harrington, R A, Ohman, E M, White, H D, Wallentin, L, Granger, C B
(2008). Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation. Heart
94: 867-873
[Abstract][Full Text]
Schulman, S., Beyth, R. J., Kearon, C., Levine, M. N.
(2008). Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest
133: 257S-298S
[Abstract][Full Text]
Harrington, R. A., Becker, R. C., Cannon, C. P., Gutterman, D., Lincoff, A. M., Popma, J. J., Steg, G., Guyatt, G. H., Goodman, S. G.
(2008). Antithrombotic Therapy for Non-ST-Segment Elevation Acute Coronary Syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest
133: 670S-707S
[Abstract][Full Text]
Goodman, S. G., Menon, V., Cannon, C. P., Steg, G., Ohman, E. M., Harrington, R. A.
(2008). Acute ST-Segment Elevation Myocardial Infarction: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest
133: 708S-775S
[Abstract][Full Text]
Mehta, R. H., Rao, S. V., Ohman, E. M., Bates, E. R., Marcucci, G., Zhang, M., Pieper, K. S., Armstrong, P. W., White, H. D., Van de Werf, F., Califf, R. M., Granger, C. B.
(2008). Variation in the use of stress testing and outcomes in patients with non-ST-elevation acute coronary syndromes: insights from GUSTO IIb. Eur Heart J
29: 880-887
[Abstract][Full Text]
Granger, C. B, Vogel, V., Cummings, S. R, Held, P., Fiedorek, F., Lawrence, M., Neal, B., Reidies, H., Santarelli, L., Schroyer, R., Stockbridge, N. L, Feng Zhao,
(2008). Do we need to adjudicate major clinical events?. Clin Trials
5: 56-60
[Abstract]
Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E. Jr, Chavey, W. E. II, Fesmire, F. M., Hochman, J. S., Levin, T. N., Lincoff, A. M., Peterson, E. D., Theroux, P., Wenger, N. K., Wright, R. S., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Krumholz, H. M., Kushner, F. G., Lytle, B. W., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B.
(2007). ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol
50: e1-e157
[Full Text]
Rosendorff, C., Black, H. R., Cannon, C. P., Gersh, B. J., Gore, J., Izzo, J. L. Jr, Kaplan, N. M., O'Connor, C. M., O'Gara, P. T., Oparil, S.
(2007). REPRINT Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Hypertension
50: e28-e55
[Full Text]
Rosendorff, C., Black, H. R., Cannon, C. P., Gersh, B. J., Gore, J., Izzo, J. L. Jr, Kaplan, N. M., O'Connor, C. M., O'Gara, P. T., Oparil, S.
(2007). Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation
115: 2761-2788
[Full Text]
Alexander, K. P., Newby, L. K., Cannon, C. P., Armstrong, P. W., Gibler, W. B., Rich, M. W., Van de Werf, F., White, H. D., Weaver, W. D., Naylor, M. D., Gore, J. M., Krumholz, H. M., Ohman, E. M.
(2007). Acute Coronary Care in the Elderly, Part I: Non-ST-Segment-Elevation Acute Coronary Syndromes: A Scientific Statement for Healthcare Professionals From the American Heart Association Council on Clinical Cardiology: In Collaboration With the Society of Geriatric Cardiology. Circulation
115: 2549-2569
[Abstract][Full Text]
Fox, K. A. A., Steg, P. G., Eagle, K. A., Goodman, S. G., Anderson, F. A. Jr, Granger, C. B., Flather, M. D., Budaj, A., Quill, A., Gore, J. M., for the GRACE Investigators,
(2007). Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006. JAMA
297: 1892-1900
[Abstract][Full Text]
Christersson, C., Oldgren, J., Bylock, A., Siegbahn, A., Wallentin, L.
(2007). Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: observations from the ESTEEM trial. Eur Heart J
28: 692-698
[Abstract][Full Text]
Mehta, R. H., Califf, R. M., Garg, J., White, H. D., Van de Werf, F., Armstrong, P. W., Pieper, K. S., Topol, E. J., Granger, C. B.
(2007). The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarction. Eur Heart J
28: 415-424
[Abstract][Full Text]
Mahaffey, K. W., Roe, M. T., Kilaru, R., Alexander, J. H., Van de Werf, F., Califf, R. M., Simoons, M. L., Topol, E. J., Harrington, R. A.
(2007). Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trials. Eur Heart J
28: 425-432
[Abstract][Full Text]
Collet, J.-P., Dumaine, R., Montalescot, G.
(2007). Antithrombin treatment in patients with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention. Eur Heart J Suppl
9: A11-A24
[Abstract][Full Text]
Dzau, V. J., Antman, E. M., Black, H. R., Hayes, D. L., Manson, J. E., Plutzky, J., Popma, J. J., Stevenson, W.
(2006). The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part II: Clinical Trial Evidence (Acute Coronary Syndromes Through Renal Disease) and Future Directions. Circulation
114: 2871-2891
[Full Text]
Westerhout, C. M., Hernandez, A. V., Steyerberg, E. W., Bueno, H., White, H., Theroux, P., Moliterno, D. J., Armstrong, P. W., Califf, R. M., Wallentin, L. C., Simoons, M. L., Boersma, E.
(2006). Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromes. Eur Heart J
27: 2956-2961
[Abstract][Full Text]
Collet, J.-P., Montalescot, G., Le May, M., Borentain, M., Gershlick, A.
(2006). Percutaneous Coronary Intervention After Fibrinolysis: A Multiple Meta-Analyses Approach According to the Type of Strategy. J Am Coll Cardiol
48: 1326-1335
[Abstract][Full Text]
Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., Hart, R. G., Howard, G., Kelly-Hayes, M., Nixon, J.V., Sacco, R. L.
(2006). Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.. Circulation
113: e873-e923
[Abstract][Full Text]
Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., Hart, R. G., Howard, G., Kelly-Hayes, M., Nixon, J.V., Sacco, R. L.
(2006). Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.. Stroke
37: 1583-1633
[Abstract][Full Text]
Antman, E. M., Morrow, D. A., McCabe, C. H., Murphy, S. A., Ruda, M., Sadowski, Z., Budaj, A., Lopez-Sendon, J. L., Guneri, S., Jiang, F., White, H. D., Fox, K. A.A., Braunwald, E., the ExTRACT-TIMI 25 Investigators,
(2006). Enoxaparin versus Unfractionated Heparin with Fibrinolysis for ST-Elevation Myocardial Infarction. NEJM
354: 1477-1488
[Abstract][Full Text]
Rao, S. V., O'Grady, K., Pieper, K. S., Granger, C. B., Newby, L. K., Mahaffey, K. W., Moliterno, D. J., Lincoff, A. M., Armstrong, P. W., Van de Werf, F., Califf, R. M., Harrington, R. A.
(2006). A Comparison of the Clinical Impact of Bleeding Measured by Two Different Classifications Among Patients With Acute Coronary Syndromes. J Am Coll Cardiol
47: 809-816
[Abstract][Full Text]
Brogan, G. X. Jr, Peterson, E. D., Mulgund, J., Bhatt, D. L., Ohman, E. M., Gibler, W. B., Pollack, C. V. Jr, Farkouh, M. E., Roe, M. T.
(2006). Treatment Disparities in the Care of Patients With and Without Diabetes Presenting With Non-ST-Segment Elevation Acute Coronary Syndromes. Diabetes Care
29: 9-14
[Abstract][Full Text]
Sinnaeve, P. R., Simes, J., Yusuf, S., Garg, J., Mehta, S., Eikelboom, J., Bittl, J. A., Serruys, P., Topol, E. J., Granger, C. B.
(2005). Direct thrombin inhibitors in acute coronary syndromes: effect in patients undergoing early percutaneous coronary intervention. Eur Heart J
26: 2396-2403
[Abstract][Full Text]
Savonitto, S., Cohen, M. G., Politi, A., Hudson, M. P., Kong, D. F., Huang, Y., Pieper, K. S., Mauri, F., Wagner, G. S., Califf, R. M., Topol, E. J., Granger, C. B.
(2005). Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromes. Eur Heart J
26: 2106-2113
[Abstract][Full Text]
Kaul, P, Newby, L K, Fu, Y, Mark, D B, Goodman, S G, Wagner, G S, Harrington, R A, Granger, C B, Van de Werf, F, Ohman, E M, Armstrong, P W, for the VIGOUR Group,
(2005). Relation between baseline risk and treatment decisions in non-ST elevation acute coronary syndromes: an examination of international practice patterns. Heart
91: 876-881
[Abstract][Full Text]
Hirsh, J., O'Donnell, M., Weitz, J. I.
(2005). New anticoagulants. Blood
105: 453-463
[Abstract][Full Text]
Labinaz, M., Mathias, J., Pieper, K., Granger, C. B., Lincoff, A. M., Moliterno, D. J., Van de Werf, F., Simes, J., White, H. D., Simoons, M. L., Califf, R. M., Topol, E. J., Armstrong, P. W., Harrington, R. A.
(2005). Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials. Eur Heart J
26: 128-136
[Abstract][Full Text]
Rao, S. V., Jollis, J. G., Harrington, R. A., Granger, C. B., Newby, L. K., Armstrong, P. W., Moliterno, D. J., Lindblad, L., Pieper, K., Topol, E. J., Stamler, J. S., Califf, R. M.
(2004). Relationship of Blood Transfusion and Clinical Outcomes in Patients With Acute Coronary Syndromes. JAMA
292: 1555-1562
[Abstract][Full Text]
Hirsh, J., Raschke, R.
(2004). Heparin and Low-Molecular-Weight Heparin: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest
126: 188S-203S
[Abstract][Full Text]
Weitz, J. I., Hirsh, J., Samama, M. M.
(2004). New Anticoagulant Drugs: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest
126: 265S-286S
[Abstract][Full Text]
Harrington, R. A., Becker, R. C., Ezekowitz, M., Meade, T. W., O'Connor, C. M., Vorchheimer, D. A., Guyatt, G. H.
(2004). Antithrombotic Therapy for Coronary Artery Disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest
126: 513S-548S
[Abstract][Full Text]
Quinn, M. J., Aronow, H. D., Califf, R. M., Bhatt, D. L., Sapp, S., Kleiman, N. S., Harrington, R. A., Kong, D. F., Kandzari, D. E., Topol, E. J.
(2004). Aspirin dose and six-month outcome after an acute coronary syndrome. J Am Coll Cardiol
43: 972-978
[Abstract][Full Text]
Roe, M.T., Mahaffey, K.W., Kilaru, R., Alexander, J.H., Akkerhuis, K.M., Simoons, M.L., Harrington, R.A., Tardiff, B.E., Granger, C.B., Ohman, E.M., Moliterno, D.J., Lincoff, A.M., Armstrong, P.W., Van de Werf, F., Califf, R.M., Topol, E.J.
(2004). Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes. Eur Heart J
25: 313-321
[Abstract][Full Text]
Granger, C. B., Goldberg, R. J., Dabbous, O., Pieper, K. S., Eagle, K. A., Cannon, C. P., Van de Werf, F., Avezum, A., Goodman, S. G., Flather, M. D., Fox, K. A. A.
(2003). Predictors of Hospital Mortality in the Global Registry of Acute Coronary Events. Arch Intern Med
163: 2345-2353
[Abstract][Full Text]
Khot, U. N., Jia, G., Moliterno, D. J., Lincoff, A. M., Khot, M. B., Harrington, R. A., Topol, E. J.
(2003). Prognostic Importance of Physical Examination for Heart Failure in Non-ST-Elevation Acute Coronary Syndromes: The Enduring Value of Killip Classification. JAMA
290: 2174-2181
[Abstract][Full Text]
Ardissino, D., Merlini, P. A., Bauer, K. A., Galvani, M., Ottani, F., Franchi, F., Bertocchi, F., Rosenberg, R. D., Mannucci, P. M.
(2003). Coagulation activation and long-term outcome in acute coronary syndromes. Blood
102: 2731-2735
[Abstract][Full Text]
Bates, S. M., Weitz, J. I.
(2003). Emerging Anticoagulant Drugs. Arterioscler. Thromb. Vasc. Bio.
23: 1491-1500
[Abstract][Full Text]
Khot, U. N., Khot, M. B., Bajzer, C. T., Sapp, S. K., Ohman, E. M., Brener, S. J., Ellis, S. G., Lincoff, A. M., Topol, E. J.
(2003). Prevalence of Conventional Risk Factors in Patients With Coronary Heart Disease. JAMA
290: 898-904
[Abstract][Full Text]
Velazquez, E. J., Pfeffer, M. A., McMurray, J. V., Maggioni, A. P., Rouleau, J.-L., Van de Werf, F., Kober, L., White, H. D., Swedberg, K., Leimberger, J. D., Gallo, P., Sellers, M. A., Edwards, S., Henis, M., Califf, R. M., for the VALIANT Investigators,
(2003). VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context. Eur J Heart Fail
5: 537-544
[Abstract][Full Text]
Cannon, C. P., Turpie, A. G.G.
(2003). Unstable Angina and Non-ST-Elevation Myocardial Infarction: Initial Antithrombotic Therapy and Early Invasive Strategy. Circulation
107: 2640-2645
[Full Text]
Thambyrajah, J, De Belder, M.A
(2003). Management of non ST-segment elevation acute coronary syndromes--continuing the search for the bad guys. Eur Heart J
24: 490-493
[Full Text]
Janzon, M, Levin, L-A, Swahn, E
(2003). Cost effectiveness of extended treatment with low molecular weight heparin (dalteparin) in unstable coronary artery disease: results from the FRISC II trial. Heart
89: 287-292
[Abstract][Full Text]
Eikelboom, J., White, H., Yusuf, S.
(2003). The evolving role of direct thrombin inhibitors in acute coronary syndromes. J Am Coll Cardiol
41: 70S-78S
[Abstract][Full Text]
The Task Force on the Management of Acute Myocardi, , Van de Werf, F., Ardissino, D., Betriu, A., Cokkinos, D. V., Falk, E., Fox, K. A.A., Julian, D., Lengyel, M., Neumann, F.-J., Ruzyllo, W., Thygesen, C., Underwood, S. R., Vahanian, A., Verheugt, F. W.A., Wijns, W.
(2003). Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J
24: 28-66
[Full Text]
Esslinger, H.-U., Kohne, S., Radziwon, P., Walenga, J. M., Breddin, H. K.
(2003). Effects of PEG-Hirudin in Clotting Parameters and Platelet Function and its Interaction with Aspirin in Healthy Volunteers. CLIN APPL THROMB HEMOST
9: 79-88
[Abstract]
Bertrand, M. E., Simoons, M. L., Fox, K. A.A., Wallentin, L. C., Hamm, C. W., McFadden, E., De Feyter, P. J., Specchia, G., Ruzyllo, W.
(2002). Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J
23: 1809-1840
[Full Text]
Baker, W. F. Jr
(2002). Thrombolytic Therapy. CLIN APPL THROMB HEMOST
8: 291-314
Al Suwaidi, J., Reddan, D. N., Williams, K., Pieper, K. S., Harrington, R. A., Califf, R. M., Granger, C. B., Ohman, E. M., Holmes, D. R. Jr, for the GUSTO-IIb, GUSTO-III, PURSUIT, and PARAGON,
(2002). Prognostic Implications of Abnormalities in Renal Function in Patients With Acute Coronary Syndromes. Circulation
106: 974-980
[Abstract][Full Text]
Kottke-Marchant, K., Bahit, M.C., Granger, C.B., Zoldhelyi, P., Ardissino, D., Brooks, L., Griffin, J.H., Potthoff, R.F., Van de Werf, F., Califf, R.M., Topol, E.J.
(2002). Effect of hirudin vs heparin on haemostatic activity in patients with acute coronary syndromes. Eur Heart J
23: 1202-1212
[Abstract][Full Text]
Al-Khatib, S. M., Granger, C. B., Huang, Y., Lee, K. L., Califf, R. M., Simoons, M. L., Armstrong, P. W., Van de Werf, F., White, H. D., Simes, R. J., Moliterno, D. J., Topol, E. J., Harrington, R. A.
(2002). Sustained Ventricular Arrhythmias Among Patients With Acute Coronary Syndromes With No ST-Segment Elevation: Incidence, Predictors, and Outcomes. Circulation
106: 309-312
[Abstract][Full Text]
Scott, K
(2002). Is hirudin a potential therapeutic agent for arthritis?. Ann Rheum Dis
61: 561-562
[Full Text]
Van de Werf, F.J., Antman, E.M., Simoons, M.L.
(2002). Managing ST elevation myocardial infarction. Eur Heart J Suppl
4: E15-E23
[Abstract]
Ambrose, J. A., Martinez, E. E.
(2002). A New Paradigm for Plaque Stabilization. Circulation
105: 2000-2004
[Abstract][Full Text]
Brouwer, M. A., Verheugt, F. W.A.
(2002). Oral Anticoagulation for Acute Coronary Syndromes. Circulation
105: 1270-1274
[Full Text]
Prieto, A. R, Ma, H., Huang, R., Khan, G., Schwartz, K. A, Hage-Korban, E. E, Schmaier, A. H, Davis, J. M, Hasan, A. A.K, Abela, G. S
(2002). Thrombostatin, a bradykinin metabolite, reduces platelet activation in a model of arterial wall injury. Cardiovasc Res
53: 984-992
[Abstract][Full Text]
Weitz, J. I., Buller, H. R.
(2002). Direct Thrombin Inhibitors in Acute Coronary Syndromes: Present and Future. Circulation
105: 1004-1011
[Full Text]
White, H. D., Wong, C. K.
(2002). Risk stratification and treatment benefits in patients with non-ST-elevation acute coronary syndromes. Eur Heart J
23: 187-191
[Full Text]
Savonitto, S., Granger, C. B., Ardissino, D., Gardner, L., Cavallini, C., Galvani, M., Ottani, F., White, H. D., Armstrong, P. W., Ohman, E. M., Pieper, K. S., Califf, R. M., Topol, E. J., GUSTO-IIb Investigators,
(2002). The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromes. J Am Coll Cardiol
39: 22-29
[Abstract][Full Text]
Cannon, C. P., Battler, A., Brindis, R. G., Cox, J. L., Ellis, S. G., Every, N. R., Flaherty, J. T., Harrington, R. A., Krumholz, H. M., Simoons, M. L., Van De Werf, F. J. J., Weintraub, W. S., Mitchell, K. R., Morrisson, S. L., Brindis, R. G., Anderson, H. V., Cannom, D. S., Chitwood, W. R. Jr, Cigarroa, J. E., Collins-Nakai, R. L., Ellis, S. G., Gibbons, R. J., Grover, F. L., Heidenreich, P. A., Khandheria, B. K., Knoebel, S. B., Krumholz, H. L., Malenka, D. J., Mark, D. B., Mckay, C. R., Passamani, E. R., Radford, M. J., Riner, R. N., Schwartz, J. B., Shaw, R. E., Shemin, R. J., Van Fossen, D. B., Verrier, E. D., Watkins, M. W., Phoubandith, D. R., Furnelli, T.
(2001). American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes: A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee) Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, American College of Emergency Physicians, American Heart Association, Cardiac Society of Australia & New Zealand, National Heart Foundation of Australia, Society for Cardiac Angiography and Interventions, and the Taiwan Society of Cardiology. J Am Coll Cardiol
38: 2114-2130
[Full Text]
Newby, D. E, Fox, K. A A
(2001). Unstable angina: the first 48 hours and later in-hospital management. Br Med Bull
59: 69-87
[Abstract][Full Text]
Llevadot, J., Giugliano, R. P., Antman, E. M.
(2001). Bolus Fibrinolytic Therapy in Acute Myocardial Infarction. JAMA
286: 442-449
[Abstract][Full Text]
Kaul, P., Fu, Y., Chang, W.-C., Harrington, R. A., Wagner, G. S., Goodman, S. G., Granger, C. B., Moliterno, D. J., Van de Werf, F., Califf, R. M., Topol, E. J., Armstrong, P. W., for the PARAGON-A and GUSTO-IIb Investigators,
(2001). Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. J Am Coll Cardiol
38: 64-71
[Abstract][Full Text]
Hirsh, J., Anand, S. S., Halperin, J. L., Fuster, V.
(2001). Guide to Anticoagulant Therapy: Heparin : A Statement for Healthcare Professionals From the American Heart Association. Arterioscler. Thromb. Vasc. Bio.
21
: e9-e9
[Full Text]
Hirsh, J., Anand, S. S., Halperin, J. L., Fuster, V.
(2001). Guide to Anticoagulant Therapy: Heparin : A Statement for Healthcare Professionals From the American Heart Association. Circulation
103: 2994-3018
[Full Text]
Lopez-Sendon, J.
(2001). Coronary reperfusion in the clinical setting: antithrombotic support to thrombolysis in the coronary care unit. Eur Heart J Suppl
3: C55-C61
[Abstract]
Antman, E. M.
(2001). The Search for Replacements for Unfractionated Heparin. Circulation
103: 2310-2314
[Full Text]
Levine, G. N., Ali, M. N., Schafer, A. I.
(2001). Antithrombotic Therapy in Patients With Acute Coronary Syndromes. Arch Intern Med
161: 937-948
[Abstract][Full Text]
De Lorenzo, F., Noorani, A., Kakkar, V.V.
(2001). Current trends in the management of thromboembolic events. QJM
94: 179-185
[Full Text]
Bahit, M. C., Topol, E. J., Califf, R. M., Armstrong, P. W., Criger, D. A., Hasselblad, V., Betriu, A., Hirsh, J., Ardissino, D., Granger, C. B.
(2001). Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. J Am Coll Cardiol
37: 1001-1007
[Abstract][Full Text]
Greinacher, A., Lubenow, N.
(2001). Recombinant Hirudin in Clinical Practice : Focus on Lepirudin. Circulation
103: 1479-1484
[Abstract][Full Text]
Armstrong, P. W., Granger, C., Van de Werf, F.
(2001). Bolus Fibrinolysis : Risk, Benefit, and Opportunities. Circulation
103: 1171-1173
[Full Text]
Becker, R. C., Burns, M., Every, N., Maynard, C., Frederick, P., Spencer, F. A., Gore, J. M., Lambrew, C., for the National Registry of Myocardial Infarction,
(2001). Early Clinical Outcomes and Routine Management of Patients With Non-ST-Segment Elevation Myocardial Infarction: A Nationwide Perspective. Arch Intern Med
161: 601-607
[Abstract][Full Text]
Rauch, U., Osende, J. I., Fuster, V., Badimon, J. J., Fayad, Z., Chesebro, J. H.
(2001). Thrombus Formation on Atherosclerotic Plaques: Pathogenesis and Clinical Consequences. ANN INTERN MED
134: 224-238
[Abstract][Full Text]
Eikelboom, J. W., Anand, S. S., Mehta, S. R., Weitz, J. I., Yi, C., Yusuf, S.
(2001). Prognostic Significance of Thrombocytopenia During Hirudin and Heparin Therapy in Acute Coronary Syndrome Without ST Elevation : Organization to Assess Strategies for Ischemic Syndromes (OASIS-2) Study. Circulation
103: 643-650
[Abstract][Full Text]
British Cardiac Society Guidelines and Medical Pra, , Royal College of Physicians Clinical Effectiveness,
(2001). Guideline for the management of patients with acute coronary syndromes without persistent ECG ST segment elevation. Heart
85: 133-142
[Full Text]
Goldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., Hademenos, G., Hill, M., Howard, G., Howard, V. J., Jacobs, B., Levine, S. R., Mosca, L., Sacco, R. L., Sherman, D. G., Wolf, P. A., del Zoppo, G. J., Members,
(2001). Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association. Circulation
103: 163-182
[Full Text]
Goldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., Hademenos, G., Hill, M., Howard, G., Howard, V. J., Jacobs, B., Levine, S. R., Mosca, L., Sacco, R. L., Sherman, D. G., Wolf, P. A., del Zoppo, G. J.
(2001). Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association. Stroke
32: 280-299
[Full Text]
Weitz, J. I., Hirsh, J.
(2001). New Anticoagulant Drugs. Chest
119
: 95S-107S
[Full Text]
Cairns, J. A., Theroux, P., Lewis, H. D. Jr., Ezekowitz, M., Meade, T. W.
(2001). Antithrombotic Agents in Coronary Artery Disease. Chest
119
: 228S-252S
[Full Text]
Ohman, E. M., Harrington, R. A., Cannon, C. P., Agnelli, G., Cairns, J. A., Kennedy, J.W.
(2001). Intravenous Thrombolysis in Acute Myocardial Infarction. Chest
119
: 253S-277S
[Full Text]
White, H.D.
(2000). Cardiogenic shock: a more aggressive approach is now warranted. Eur Heart J
21: 1897-1901
Manhapra, A., Borzak, S.
(2000). Regular review: Treatment possibilities for unstable angina. BMJ
321: 1269-1275
[Full Text]
McGuire, D.K, Emanuelsson, H, Granger, C.B, Magnus Ohman, E, Moliterno, D.J, White, H.D, Ardissino, D, Box, J.W, Califf, R.M, Topol, E.J
(2000). Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb Study. Eur Heart J
21: 1750-1758
[Abstract]
Eichler, P., Friesen, H.-J., Lubenow, N., Jaeger, B., Greinacher, A.
(2000). Antihirudin antibodies in patients with heparin-induced thrombocytopenia treated with lepirudin: incidence, effects on aPTT, and clinical relevance. Blood
96: 2373-2378
[Abstract][Full Text]
Fu, Y., Chang, W.-C., Mark, D., Califf, R. M., Mackenzie, B., Granger, C. B., Topol, E. J., Hlatky, M., Armstrong, P. W.
(2000). Canadian-American Differences in the Management of Acute Coronary Syndromes in the GUSTO IIb Trial : One-Year Follow-Up of Patients Without ST-Segment Elevation. Circulation
102: 1375-1381
[Abstract][Full Text]
Lincoff, A. M., Harrington, R. A., Califf, R. M., Hochman, J. S., Guerci, A. D., Ohman, E. M., Pepine, C. J., Kopecky, S. L., Kleiman, N. S., Pacchiana, C. M., Berdan, L. G., Kitt, M. M., Simoons, M. L., Topol, E. J.
(2000). Management of Patients With Acute Coronary Syndromes in the United States by Platelet Glycoprotein IIb/IIIa Inhibition : Insights From the Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial. Circulation
102: 1093-1100
[Abstract][Full Text]
Roe, M. T., Harrington, R. A., Prosper, D. M., Pieper, K. S., Bhatt, D. L., Lincoff, A. M., Simoons, M. L., Akkerhuis, M., Ohman, E. M., Kitt, M. M., Vahanian, A., Ruzyllo, W., Karsch, K., Califf, R. M., Topol, E. J.
(2000). Clinical and Therapeutic Profile of Patients Presenting With Acute Coronary Syndromes Who Do Not Have Significant Coronary Artery Disease. Circulation
102: 1101-1106
[Abstract][Full Text]
Previous
